Pfizer Investigational Site is a clinical research site located in Temple, Texas, United States 76508.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Pfizer Investigational Site has participated in 11 clinical trials.
Therapeutic areas: Pulmonary Arterial Hypertension, Pulmonary Hypertension, Macular Edema Associated With Diabetes Mellitus.
Sponsors: Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Pfizer Investigational Site has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Pfizer Investigational Site has 11 clinical trials on record. Their work covers Pulmonary Arterial Hypertension, Pulmonary Hypertension, Macular Edema Associated With Diabetes Mellitus.
Yes — Pfizer Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.